Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2012, Article ID 245835, 9 pages
http://dx.doi.org/10.1155/2012/245835
Research Article

Effects of Atelocollagen Formulation Containing Oligonucleotide on Endothelial Permeability

1Formulation Research and Development Laboratories, Dainippon Sumitomo Pharma Co., Ltd., 1-3-45 Kurakakiuchi, Ibaraki-shi, Osaka 567-0878, Japan
2Department of Pathology, Sapporo Medical University School of Medicine, S1, W17, Sapporo 060-8556, Japan
3Environmental Health Science Laboratory, Sumitomo Chemical Co., Ltd., Osaka 554-0022, Japan
4Research Institute, Koken Co., Ltd., 2-13-10, Ukima, Kita-ku, Tokyo 115-0051, Japan

Received 29 August 2011; Revised 11 December 2011; Accepted 12 December 2011

Academic Editor: Rassoul Dinarvand

Copyright © 2012 Koji Hanai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Miyata, T. Taira, and Y. Noishiki, “Collagen engineering for biomaterial use,” Clinical Materials, vol. 9, no. 3-4, pp. 139–148, 1992. View at Google Scholar · View at Scopus
  2. K. Fujioka, M. Maeda, T. Hojo, and A. Sano, “Protein release from collagen matrices,” Advanced Drug Delivery Reviews, vol. 31, no. 3, pp. 247–266, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Marumo, M. Oya, M. Murai, and H. Tazaki, “Application of cytokine drug delivery systems to the immunotherapy of renal cell carcinoma in mice,” International Journal of Urology, vol. 3, supplement 1, pp. S24–S27, 1996. View at Google Scholar · View at Scopus
  4. T. Fujiwara, K. Sakagami, and K. Orita, “Antitumor effects of a new interleukin-2 slow delivery system on methylcholanthrene-induced fibrosarcoma in mice,” Journal of Cancer Research and Clinical Oncology, vol. 116, no. 2, pp. 141–148, 1990. View at Publisher · View at Google Scholar · View at Scopus
  5. O. Takemoto, T. Yoshimine, A. K. M. G. Muhammad et al., “Distribution of nerve growth factor in cat brains following topical application of solution or Minipellet,” Neurological Research, vol. 20, no. 2, pp. 116–120, 1998. View at Google Scholar · View at Scopus
  6. H. Maeda, A. Sano, and K. Fujioka, “Controlled release of rhBMP-2 from collagen minipellet and the relationship between release profile and ectopic bone formation,” International Journal of Pharmaceutics, vol. 275, no. 1-2, pp. 109–122, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Nakamura, Y. Ando, S. Nagahara et al., “Targeted conversion of the transthyretin gene in vitro and in vivo,” Gene Therapy, vol. 11, no. 10, pp. 838–846, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Hanai, T. Kurokawa, Y. Minakuchi et al., “Potential of atelocollagen-mediated systemic antisense therapeutics for inflammatory disease,” Human Gene Therapy, vol. 15, no. 3, pp. 263–272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Ishimoto, Y. Takei, Y. Yuzawa et al., “Downregulation of monocyte chemoattractant protein-1 involving short interfering RNA attenuates hapten-induced contact hypersensitivity,” Molecular Therapy, vol. 16, no. 2, pp. 387–395, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ochiya, Y. Takahama, S. Nagahara et al., “New delivery system for plasmid DNA in vivo using atelocollagen as a carrier material: the Minipellet,” Nature Medicine, vol. 5, no. 6, pp. 707–710, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Hirai, H. Sasaki, H. Sakamoto et al., “Antisense oligodeoxynucleotide against HST-1/FGF-4 suppresses tumorigenicity of an orthotopic model for human germ cell tumor in nude mice,” Journal of Gene Medicine, vol. 5, no. 11, pp. 951–957, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Takei, K. Kadomatsu, K. Yuasa, W. Sato, and T. Muramatsu, “Morpholino antisense oligomer targeting human midkine: its application for cancer therapy,” International Journal of Cancer, vol. 114, no. 3, pp. 490–497, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Nakazawa, T. Nemoto, T. Hata et al., “Single-injection ornithine decarboxylase-directed antisense therapy using atelocollagen to suppress human cancer growth,” Cancer, vol. 109, no. 5, pp. 993–1002, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Minakuchi, F. Takeshita, N. Kosaka et al., “Atelocollagen-mediated synthetic small interfering RNA delivery for effective gene silencing in vitro and in vivo,” Nucleic acids research, vol. 32, no. 13, p. e109, 2004. View at Google Scholar · View at Scopus
  15. F. Takeshita, Y. Minakuchi, S. Nagahara et al., “Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 34, pp. 12177–12182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Mu, S. Nagahara, N. Makita, Y. Tarumi, K. Kadomatsu, and Y. Takei, “Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer,” International Journal of Cancer, vol. 125, no. 12, pp. 2978–2990, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. E. Ashihara, E. Kawata, Y. Nakagawa et al., “β-catenin small interfering RNA successfully suppressed progression of multiple myeloma in a mouse model,” Clinical Cancer Research, vol. 15, no. 8, pp. 2731–2738, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Sasaki, K. Nakashiro, H. Tanaka et al., “Knockdown of Akt isoforms by RNA silencing suppresses the growth of human prostate cancer cells in vitro and in vivo,” Biochemical and Biophysical Research Communications, vol. 399, no. 1, pp. 79–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. I. Takigami, T. Ohno, Y. Kitade et al., “Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model,” International Journal of Cancer, vol. 128, no. 1, pp. 216–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Kawata, E. Ashihara, S. Kimura et al., “Administration of PLK-1 small interfering RNA with atelocollagen prevents the growth of liver metastases of lung cancer,” Molecular Cancer Therapeutics, vol. 7, no. 9, pp. 2904–2912, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Tazawa, N. Tsuchiya, M. Izumiya, and H. Nakagama, “Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15472–15477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Takeshita, L. Patrawala, M. Osaki et al., “Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes,” Molecular Therapy, vol. 18, no. 1, pp. 181–187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Takei, M. Takigahira, K. Mihara, Y. Tarumi, and K. Yanagihara, “The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer,” Cancer Research, vol. 71, no. 4, pp. 1442–1453, 2011. View at Publisher · View at Google Scholar
  24. Y. Takei, K. Kadomatsu, Y. Yuzawa, S. Matsuo, and T. Muramatsu, “A small interfering RNA targeting vascular endothelial growth factor as cancer therapeutics,” Cancer Research, vol. 64, no. 10, pp. 3365–3370, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. S. K. Klimuk, S. C. Semple, P. N. Nahirney et al., “Enhanced anti-inflammatory activity of a liposomal intercellular adhesion molecule-1 antisense oligodeoxynucleotide in an acute model of contact hypersensitivity,” Journal of Pharmacology and Experimental Therapeutics, vol. 292, no. 2, pp. 480–488, 2000. View at Google Scholar · View at Scopus
  26. K. L. Sewell, R. S. Geary, B. F. Baker et al., “Phase I trial of ISIS 104838, a 2-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-α,” Journal of Pharmacology and Experimental Therapeutics, vol. 303, no. 3, pp. 1334–1343, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Nagasawa, H. Chiba, H. Fujita et al., “Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells,” Journal of Cellular Physiology, vol. 208, no. 1, pp. 123–132, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Soma, H. Chiba, Y. Kato-Mori et al., “Thr207 of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP,” Experimental Cell Research, vol. 300, no. 1, pp. 202–212, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Kojima, J. Fuchimoto, H. Yamaguchi et al., “c-Jun N-terminal kinase is largely involved in the regulation of tricellular tight junctions via tricellulin in human pancreatic duct epithelial cells,” Journal of Cellular Physiology, vol. 225, no. 3, pp. 720–733, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Salamat-Miller and T. P. Johnston, “Current strategies used to enhance the paracellular transport of therapeutic polypeptides across the intestinal epithelium,” International Journal of Pharmaceutics, vol. 294, no. 1-2, pp. 201–216, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. C. M. Van Itallie and J. M. Anderson, “Claudins and epithelial paracellular transport,” Annual Review of Physiology, vol. 68, pp. 403–429, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. V. Vouret-Craviari, P. Boquet, J. Pouysségur, and E. Van Obberghen-Schilling, “Regulation of the actin cytoskeleton by thrombin in human endothelial cells: role of Rho proteins in endothelial barrier function,” Molecular Biology of the Cell, vol. 9, no. 9, pp. 2639–2653, 1998. View at Google Scholar · View at Scopus
  33. Y. Yuan, H. J. Granger, D. C. Zawieja, D. V. DeFily, and W. M. Chilian, “Histamine increases venular permeability via a phospholipase C-NO synthase-guanylate cyclase cascade,” American Journal of Physiology, vol. 264, no. 5, pp. H1734–H1739, 1993. View at Google Scholar · View at Scopus
  34. B. Wójciak-Stothard, A. Entwistle, R. Garg, and A. J. Ridley, “Regulation of TNF-α-induced reorganization of the actin cytoskeleton and cell-cell junctions by Rho, Rac, and Cdc42 in human endothelial cells,” Journal of Cellular Physiology, vol. 176, no. 1, pp. 150–165, 1998. View at Google Scholar · View at Scopus
  35. M. Puhlmann, D. M. Weinreich, J. M. Farma, N. M. Carroll, E. M. Turner, and H. R. Alexander, “Interleukin-1β induced vascular permeability is dependent on induction of endothelial tissue factor (TF) activity,” Journal of Translational Medicine, vol. 3, article 37, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. I. Petrache, A. Birukova, S. I. Ramirez, J. G. N. Garcia, and A. D. Verin, “The role of the microtubules in tumor necrosis factor-α-induced endothelial cell permeability,” American Journal of Respiratory Cell and Molecular Biology, vol. 28, no. 5, pp. 574–581, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. K. M. Smurova, A. A. Birukova, A. D. Verin, and I. B. Alieva, “Microtubule system in endothelial barrier dysfunction: disassembly of peripheral microtubules and microtubule reorganization in internal cytoplasm,” Cell and Tissue Biology, vol. 2, no. 1, pp. 45–52, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Wójciak-Stothard, S. Potempa, T. Eichholtz, and A. J. Ridley, “Rho and Rac but not Cdc42 regulate endothelial cell permeability,” Journal of Cell Science, vol. 114, no. 7, pp. 1343–1355, 2001. View at Google Scholar · View at Scopus
  39. A. Blois, B. Srebro, M. Mandalà, A. Corti, K. B. Helle, and G. Serck-Hanssen, “The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells,” Regulatory Peptides, vol. 135, no. 1-2, pp. 78–84, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. Z. G. Chu, J. P. Zhang, H. P. Song et al., “P38 map kinase mediates burn serum-induced endothelial barrier dysfunction: involvement of F-actin rearrangement and L-caldesmon phosphorylation,” Shock, vol. 34, no. 3, pp. 222–228, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. D. Yang, P. Xie, S. Guo, and H. Li, “Induction of MAPK phosphatase-1 by hypothermia inhibits TNF-induced endothelial barrier dysfunction and apoptosis,” Cardiovascular Research, vol. 85, no. 3, pp. 520–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. C. G. Kevil, T. Oshima, and S. Alexander, “The role of p38 MAP kinase in hydrogen peroxide mediated endothelial solute permeability,” Endothelium, vol. 8, no. 2, pp. 107–116, 2001. View at Google Scholar · View at Scopus
  43. B. K. Lal, S. Varma, P. J. Pappas, R. W. Hobson, and W. N. Durán, “VEGF increases permeability of the endothelial cell monolayer by activation of PKB/akt, endothelial nitric-oxide synthase, and MAP kinase pathways,” Microvascular Research, vol. 62, no. 3, pp. 252–262, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. N. N. Salama, N. D. Eddington, and A. Fasano, “Tight junction modulation and its relationship to drug delivery,” Advanced Drug Delivery Reviews, vol. 58, no. 1, pp. 15–28, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. L. González-Mariscal, P. Nava, and S. Hernández, “Critical role of tight junctions in drug delivery across epithelial and endothelial cell layers,” Journal of Membrane Biology, vol. 207, no. 2, pp. 55–68, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. K. Matsuhisa, M. Kondoh, A. Takahashi, and K. Yagi, “Tight junction modulator and drug delivery,” Expert Opinion on Drug Delivery, vol. 6, no. 5, pp. 509–515, 2009. View at Publisher · View at Google Scholar · View at Scopus